Yes, it sure seems like the Recovery RX is getting vocalized much more by the company. Actipatch held the headlines for years, but now that OEM's are controlling sales and advertising of Actipatch, it seems like their attention has shifted seriously to RX. Would not surprise me one bit if RX is an important topic in August 25 CC. They have had some time since the RX sales force has been hitting the streets 'pushing' the product. Could this CC contain the good news that many of us longs have been waiting to hear? RX price is much more than Actipatch and if widely accepted in the surgical departments of many medical centers, this could be the monster unleashed!
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links